• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

FDA’s plan to expand device surveillance faces challenges, GAO finds

cafead

Administrator
Staff member
  • cafead   Aug 21, 2024 at 10:52: PM
via Funding issues and limited use of unique device identifiers are hurdles to expanding an FDA system to monitor medical device safety, the federal watchdog said.

article source